Cargando…

Risk-prediction models for intravenous immunoglobulin resistance in Kawasaki disease: Risk-of-Bias Assessment using PROBAST

BACKGROUND: The prediction model of intravenous immunoglobulin (IVIG) resistance in Kawasaki disease can calculate the probability of IVIG resistance and provide a basis for clinical decision-making. We aim to assess the quality of these models developed in the children with Kawasaki disease. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shuhui, Huang, Hongbiao, Hou, Miao, Xu, Qiuqin, Qian, Weiguo, Tang, Yunjia, Li, Xuan, Qian, Guanghui, Ma, Jin, Zheng, Yiming, Shen, Yueping, Lv, Haitao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2023
Materias:	Clinical Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444619/ https://www.ncbi.nlm.nih.gov/pubmed/36964445 http://dx.doi.org/10.1038/s41390-023-02558-6

Ejemplares similares

Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children: a meta-analysis of 4442 cases
por: Li, Xuan, et al.
Publicado: (2018)

Bioinformatics identification of hub genes and signaling pathways regulated by intravenous immunoglobulin treatment in acute Kawasaki disease
por: Huang, Hongbiao, et al.
Publicado: (2021)

A comparison of efficacy of six prediction models for intravenous immunoglobulin resistance in Kawasaki disease
por: Qian, Weiguo, et al.
Publicado: (2018)

Nomogram to predict risk of resistance to intravenous immunoglobulin in children hospitalized with Kawasaki disease in Eastern China
por: Huang, Hongbiao, et al.
Publicado: (2022)

Neutropenia Is Not Associated With the Outcomes in Patients With Kawasaki Disease
por: Tang, Yunjia, et al.
Publicado: (2021)

A novel model for predicting intravenous immunoglobulin-resistance in Kawasaki disease: a large cohort study
por: Wang, Shuhui, et al.
Publicado: (2023)

Prediction Model Risk-of-Bias Assessment Tool for coronary artery lesions in Kawasaki disease
por: Huang, Hongbiao, et al.
Publicado: (2022)

Predicting immunoglobulin resistance in Kawasaki disease: an assessment of neutrophil to lymphocyte platelet ratio
por: Lu, Yuyao, et al.
Publicado: (2022)

Using the Prediction Model Risk of Bias Assessment Tool (PROBAST) to Evaluate Melanoma Prediction Studies
por: Kaiser, Isabelle, et al.
Publicado: (2022)

Kawasaki disease associated with Mycoplasma pneumoniae
por: Tang, Yunjia, et al.
Publicado: (2016)

Breastfeeding has no protective effects on the development of coronary artery lesions in Kawasaki disease: a retrospective cohort study
por: Wang, Hongli, et al.
Publicado: (2022)

Prediction nomogram for coronary artery aneurysms at one month in Kawasaki disease
por: Tang, Yunjia, et al.
Publicado: (2023)

Characteristics and Indications of Kawasaki Disease Among Infants Under 6 Months
por: Tang, Yunjia, et al.
Publicado: (2020)

CHARMS and PROBAST at your fingertips: a template for data extraction and risk of bias assessment in systematic reviews of predictive models
por: Fernandez-Felix, Borja M., et al.
Publicado: (2023)

Appraising prediction research: a guide and meta‐review on bias and applicability assessment using the Prediction model Risk Of Bias ASsessment Tool (PROBAST)
por: de Jong, Ype, et al.
Publicado: (2021)

The role of FOXO4/NFAT2 signaling pathway in dysfunction of human coronary endothelial cells and inflammatory infiltration of vasculitis in Kawasaki disease
por: Huang, Hongbiao, et al.
Publicado: (2023)

Risk Factors and Predictive Models for Intravenous Immunoglobulin Resistance in Children with Recurrent Kawasaki Disease
por: Chen, Xi, et al.
Publicado: (2022)

Risk Factors for Failure of Initial Intravenous Immunoglobulin Treatment in Kawasaki Disease
por: Cha, Sungho, et al.
Publicado: (2008)

Intravenous immunoglobulin for the treatment of Kawasaki disease
por: Broderick, Cathryn, et al.
Publicado: (2023)

Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease
por: Piram, Maryam, et al.
Publicado: (2020)

Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease
por: Park, Hyo Min, et al.
Publicado: (2013)

Predictors and management of intravenous immunoglobulin-resistant Kawasaki disease
por: Song, Min Seob
Publicado: (2019)

Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin
por: Galeotti, Caroline, et al.
Publicado: (2010)

Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease
por: Li, Wei, et al.
Publicado: (2022)

Intravenous Immunoglobulin in Kawasaki Disease—Evolution and Pathogenic Mechanisms
por: Nadig, Pallavi L., et al.
Publicado: (2023)

Protocol for development of a reporting guideline (TRIPOD-AI) and risk of bias tool (PROBAST-AI) for diagnostic and prognostic prediction model studies based on artificial intelligence
por: Collins, Gary S, et al.
Publicado: (2021)

Inter-Rater Agreement in Assessing Risk of Bias in Melanoma Prediction Studies Using the Prediction Model Risk of Bias Assessment Tool (PROBAST): Results from a Controlled Experiment on the Effect of Specific Rater Training
por: Kaiser, Isabelle, et al.
Publicado: (2023)

FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease
por: Kuo, Ho-Chang, et al.
Publicado: (2015)

Critical Overview of the Risk Scoring Systems to Predict Non-Responsiveness to Intravenous Immunoglobulin in Kawasaki Syndrome
por: Rigante, Donato, et al.
Publicado: (2016)

Intravenous immunoglobulin-resistant Kawasaki disease: Risk factors in children in a middle-income country
por: Zahari, Norazah, et al.
Publicado: (2023)

Efficacy of Glucocorticoid plus Intravenous Immunoglobulin in Children with Immunoglobulin-Insensitive Kawasaki Disease
por: Ma, Yongmei, et al.
Publicado: (2022)

In silico Identification of 10 Hub Genes and an miRNA–mRNA Regulatory Network in Acute Kawasaki Disease
por: Ma, Jin, et al.
Publicado: (2021)

The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?
por: Han, Ji Whan
Publicado: (2017)

Prediction of Resistance to Standard Intravenous Immunoglobulin Therapy in Kawasaki Disease
por: Lee, Sang Min, et al.
Publicado: (2014)

Hemolysis From Intravenous Immunoglobulin in Obese Patients With Kawasaki Disease
por: Van Anh, Khanh-Van Y., et al.
Publicado: (2020)

Intravenous Immunoglobulin Treatment in Kawasaki Disease Decreases the Incidence of Myopia
por: Yu, Hun-Ju, et al.
Publicado: (2021)

Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease
por: Lu, Yaheng, et al.
Publicado: (2021)

Retracted: Efficacy of Glucocorticoid plus Intravenous Immunoglobulin in Children with Immunoglobulin-Insensitive Kawasaki Disease
por: Healthcare Engineering, Journal of
Publicado: (2023)

Factors Predicting Resistance to Intravenous Immunoglobulin and Coronary Complications in Kawasaki Disease: IVIG Resistance in Kawasaki Disease
por: Han, Ji Whan
Publicado: (2017)

Co-culture of peripheral blood mononuclear cell (PBMC) and human coronary artery endothelial cell (HCAEC) reveals the important role of autophagy implicated in Kawasaki disease
por: Qin, Jie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vcl9cdq50eos1mle3901sum3bg